GOODWILL AND INTANGIBLE ASSETS - Narrative (Details) - USD ($) $ in Thousands |
3 Months Ended | 9 Months Ended | ||||
---|---|---|---|---|---|---|
Sep. 30, 2022 |
Sep. 30, 2021 |
Sep. 30, 2022 |
Sep. 30, 2021 |
Mar. 31, 2022 |
Dec. 31, 2021 |
|
Goodwill | ||||||
Goodwill recorded in connection with the acquisition | $ 157,361 | $ 157,361 | $ 145,175 | |||
Amortization of acquired intangible assets | 14,322 | $ 1,967 | 42,966 | $ 5,900 | ||
Amortization expense, remainder of fiscal year | 14,300 | 14,300 | ||||
Amortization expense, first period | 57,300 | 57,300 | ||||
Amortization expense, second period | 37,400 | 37,400 | ||||
Amortization expense, third period | 7,900 | 7,900 | ||||
Amortization expense, fourth period | $ 2,200 | $ 2,200 | ||||
When annual net sales collected reach $500.0 million | Skye Pharma Holding Inc. | ||||||
Goodwill | ||||||
Milestone payments for EXPAREL agreed in connection with acquisition | $ 32,000 | |||||
Annual net sales threshold | $ 500,000 |
X | ||||||||||
- Definition Represents the milestone payments agreed to be paid by the entity for the sale of the product, in connection with the acquisition. No definition available.
|
X | ||||||||||
- Definition Represents the threshold amount of annual net sales considered to determine the stage at which a specified amount of milestone payments for product is agreed to be paid by the entity, in connection with the acquisition. No definition available.
|
X | ||||||||||
- Definition Finite-Lived Intangible Assets, Amortization Expense, Annual Amount, Period 1 No definition available.
|
X | ||||||||||
- Definition Finite-Lived Intangible Assets, Amortization Expense, Annual Amount, Period 2 No definition available.
|
X | ||||||||||
- Definition Finite-Lived Intangible Assets, Amortization Expense, Annual Amount, Period 3 No definition available.
|
X | ||||||||||
- Definition Finite-Lived Intangible Assets, Amortization Expense, Annual Amount, Period 4 No definition available.
|
X | ||||||||||
- Definition The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
X | ||||||||||
- Definition Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in remainder of current fiscal year. No definition available.
|
X | ||||||||||
- Definition Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
X | ||||||||||
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. No definition available.
|
X | ||||||||||
- Details
|
X | ||||||||||
- Details
|